Recent advances in the understanding of mastocytosis: the role of KIT mutations*
- 6 June 2007
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 138 (1), 12-30
- https://doi.org/10.1111/j.1365-2141.2007.06619.x
Abstract
Mastocytosis is a heterogeneous disorder characterised by the expansion and accumulation of mast cells in different organs and tissues. Mast cell physiology is closely dependent on activation of the stem cell factor/Kit signalling pathways and accumulating evidences confirm the physiopathological key role of activating KIT mutations (typically D816V) in mastocytosis and their relationship with the clinical manifestations of the disease. This paper reviews the most recent advances in the understanding of the molecular mechanisms associated with KIT mutations in mastocytosis, including recent data about the use of new therapies targeting the Kit molecule and its associated downstream signalling pathways.Keywords
This publication has 158 references indexed in Scilit:
- BNP as a marker of the heart failure in the treatment of imatinib mesylateCancer Letters, 2006
- Adverse effects of the humanized antibodies used as cancer therapeuticsCurrent Opinion in Oncology, 2006
- Signaling by Kit protein-tyrosine kinase—The stem cell factor receptorBiochemical and Biophysical Research Communications, 2005
- Juxtamembrane autoinhibition in receptor tyrosine kinasesNature Reviews Molecular Cell Biology, 2004
- Chromosomal abnormalities in Philadelphia chromosome‐negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia in chronic phaseCancer, 2003
- The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-KitBiochemical Journal, 2003
- Direct Association of Csk Homologous Kinase (CHK) with the Diphosphorylated Site Tyr568/570 of the Activated c-KIT in MegakaryocytesPublished by Elsevier BV ,1997
- The mast cell and mast cell diseaseJournal of the American Academy of Dermatology, 1995
- A YAC Contig Spanning a Cluster of Human Type III Receptor Protein Tyrosine Kinase Genes (PDGFRA-KIT-KDR) in Chromosome Segment 4q12Genomics, 1994
- Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and MastocytosisNew England Journal of Medicine, 1987